Angiodynamics (ANGO) Other Operating Expenses (2016 - 2026)
Angiodynamics' Other Operating Expenses history spans 17 years, with the latest figure at $30.1 million for Q1 2026.
- For Q1 2026, Other Operating Expenses changed N/A year-over-year to $30.1 million; the TTM value through Feb 2026 reached $90.2 million, changed N/A, while the annual FY2024 figure was $54.5 million, N/A changed from the prior year.
- Other Operating Expenses reached $30.1 million in Q1 2026 per ANGO's latest filing, up from $29.4 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $47.8 million in Q3 2023 to a low of $6.7 million in Q1 2024.
- Average Other Operating Expenses over 5 years is $28.9 million, with a median of $30.1 million recorded in 2026.
- The largest YoY upside for Other Operating Expenses was 11.92% in 2022 against a maximum downside of 5.94% in 2022.
- A 5-year view of Other Operating Expenses shows it stood at $31.9 million in 2022, then surged by 50.01% to $47.8 million in 2023, then plummeted by 86.09% to $6.7 million in 2024, then surged by 340.95% to $29.4 million in 2025, then grew by 2.56% to $30.1 million in 2026.
- Per Business Quant, the three most recent readings for ANGO's Other Operating Expenses are $30.1 million (Q1 2026), $29.4 million (Q4 2025), and $30.8 million (Q3 2025).